NCT03932825View on ClinicalTrials.gov

Nitrous Oxide for Major Depressive Disorder

PHASE2CompletedINTERVENTIONAL
Enrollment

44

Participants

Timeline

Start Date

April 1, 2019

Primary Completion Date

March 31, 2021

Study Completion Date

March 31, 2021

Conditions
Depressive DisorderMajor Depressive DisorderTreatment Resistant DepressionDepressive Disorder, MajorDepression
Interventions
DRUG

Nitrous Oxide

An 1-hour session of inhaled nitrous oxide at concentrations of 50%.

DRUG

Placebo

An 1-hour session of mixed oxygen-air gas(inspired oxygen concentration \~50%)

Trial Locations (1)

410001

Mental Health Institute & Faculty of Psychiatry of The Second Xiangya Hospital, Central South University, Changsha

All Listed Sponsors
lead

Lingjiang Li

OTHER

NCT03932825 - Nitrous Oxide for Major Depressive Disorder | Biotech Hunter | Biotech Hunter